Largest #Phase0 clinical trials program in the world providing personalized treatment options for patients with #glioblastoma & other aggressive brain tumors.https://bsky.app/profile/ivycenter.bsky.socialhttps://bsky.app/profile/ivycenter.bsky.social/post/3lkeorwccc22lAt the Ivy Center, we're focused on bringing patients cutting-edge treatments, combining therapies to overcome tumor resistance, and proving what works through advanced clinical trials—delivering the future of brain tumor care today. 🌐 IvyBrainTumorCenter.org14 Mar 2025 22:44 +0000at://did:plc:ojupmf3ilsgxomp74kr4jaai/app.bsky.feed.post/3lkeorwccc22lhttps://bsky.app/profile/ivycenter.bsky.social/post/3likkqluwfc2hJoin us at the Ivy Center for a firsthand look at the future of brain tumor research. Take a tour of our cutting-edge facility & see how our Phase 0 approach is making a difference for patients. Reserve your spot now by emailing us! 📅: 3/11/25 ⏰: 10-11:30 AM 📩: info@ivybraintumorcenter.org19 Feb 2025 19:58 +0000at://did:plc:ojupmf3ilsgxomp74kr4jaai/app.bsky.feed.post/3likkqluwfc2hhttps://bsky.app/profile/ivycenter.bsky.social/post/3lhvzukukv226In honor of International Day of Women & Girls in Science, we celebrate the incredible women & girls in science, who are making strides in research & innovation. Here's to the women making a difference & paving the way for future generations! 🔬💗 #WomenInScience #GirlsInSTEM11 Feb 2025 16:02 +0000at://did:plc:ojupmf3ilsgxomp74kr4jaai/app.bsky.feed.post/3lhvzukukv226https://bsky.app/profile/ivycenter.bsky.social/post/3lfsahzzr4s2kThe Ivy Center is expanding its global Phase 3 Gliofocus Study for #GBM patients with the activation of new sites in the U.S. & EU: NeuroMedical Center, @ucsdhealth.bsky.social, @pitiesalpetriere.bsky.social & Hospital Universitario 12 de Octubre. 🧠 📰 Read the full press release: loom.ly/03Wumzo15 Jan 2025 17:00 +0000at://did:plc:ojupmf3ilsgxomp74kr4jaai/app.bsky.feed.post/3lfsahzzr4s2khttps://bsky.app/profile/ivycenter.bsky.social/post/3ldyrlvmytk22📢The Gliofocus Study is now open in the EU! Led by Dr. Mehdi Touat in Paris and Dr. Juan Manuel Sepulveda Sanchez in Madrid, this Phase 3 clinical trial compares niraparib to TMZ in nGBM. 68 EU medical centers are in the global Gliofocus Study network. 🔗Gliofocus.org23 Dec 2024 20:32 +0000at://did:plc:ojupmf3ilsgxomp74kr4jaai/app.bsky.feed.post/3ldyrlvmytk22https://bsky.app/profile/ivycenter.bsky.social/post/3lcoegil7zc2tThere is hope for #braincancer patients. The Ivy Center is leading the way in #braintumor research & treatment. Learn more ➡️ IvyBrainTumorCenter.org06 Dec 2024 23:44 +0000at://did:plc:ojupmf3ilsgxomp74kr4jaai/app.bsky.feed.post/3lcoegil7zc2t